One year after initiation of cabergoline, despite apparent good compliance by the patient, blood tests revealed persistent hyperprolactinemia (73.3 μg/L (5.0–23.0 μg/L)) and a significantly increased ACTH (three times the upper limit of normal) with normal cortisol levels. The gene discussed is POMC; the disease is hyperprolactinemia.